Planet Labs PBC
NYSE:PLAerospace & Defense
+$0.01 today
- Market cap
- $4.10B
- Beta
- 2.00
- P/E (TTM)
- -26.1
- EPS (TTM)
- -$1.08
Volume 4.99M
Average 14.88M
PL Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Planet Labs PBCNYSE: PL
Capital Expenditures · Q2 FY2027 · quarter ended Jul 2026
Capital expenditures grows, but more slowly than its trailing trend
Q2 FY2027 capital expenditures of $27.35M (cash outflow) rose 48.3% year over year, behind the +86.4% change in trailing-twelve-month capital expenditures. Sequentially, it rose 58.0% from the prior quarter. Over 3 fiscal years it compounded at +81.8% a year.
Context
- Capital expenditures amounted to 24.9% of revenue in FY2026, up 6.8 pp from a year earlier.
- Capital expenditures grew in size in 3 of the last 3 fiscal years.
- FY2026 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +48.3% toward the trailing-twelve-month pace of +86.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2026
- (76.71M) USD
- Year-over-year change
- -73.2%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | (76.71M) | -73.2% |
| FY2025 | 2025-01-31 | (44.3M) | -4.4% |
| FY2024 | 2024-01-31 | (42.41M) | -232.4% |
| FY2023 | 2023-01-31 | (12.76M) | +14.5% |
| FY2022 | 2022-01-31 | (14.93M) | — |
Capital Expenditures vs competitors
How PL compares with its peers on the latest reported figures
- PL's LTM Jul 2026 capital expenditures of $94.2M is the 4th largest of the 10 companies compared; the peer median is $68.72M.
- Its year-over-year change of +86.4% is the 4th highest of 9, against a peer median of +59.4%.
- Capital expenditures amounts to 24.9% of revenue for PL, versus a peer median of 3.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $633.45M | +16.4% | -1.4% | 15.1% | |
| LTM Jun 2026 | $175.59M | +140.5% | +44.6% | 3.0% | |
| LTM Jun 2026 | $165.93M | -28.6% | -63.2% | 7.2% | |
| LTM Jul 2026 | $94.2M | +86.4% | +81.8% | 24.9% | |
| LTM Mar 2026 | $83.92M | +146.4% | +38.9% | 52.2% | |
| LTM Sep 2026 | $68.72M | — | — | 18.7% | |
| LTM Oct 2026 | $38.17M | +89.7% | +0.0% | 3.8% | |
| LTM Sep 2026 | $31.6M | -33.2% | +5.3% | 2.1% | |
| LTM Jun 2026 | $28.14M | +60.9% | +23.8% | 2.1% | |
| LTM Jul 2026 | $9.48M | +57.9% | +4.8% | 0.8% | |
| Peer median (excluding PL) | $68.72M | +59.4% | +5.0% | 3.8% | |
Competitors are the stored peer set for PL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (137.12M) | (161.97M) | (140.51M) | (123.2M) | (246.86M) |
| Depreciation & Amortization | 45.04M | 43.33M | 47.64M | 45.64M | 41.83M |
| Deferred Income Tax | (1.39M) | (456K) | 0 | 0 | 0 |
| Stock-Based Compensation | 41.96M | 75.54M | 57.13M | 48.49M | 55M |
| Change in Working Capital | 9.54M | (23.88M) | 3.8M | (2.93M) | 121.31M |
| Accounts Receivables | 3.26M | 6.31M | (2.66M) | (11.98M) | (30.23M) |
| Inventory | 0 | 0 | 0 | 0 | (609K) |
| Accounts Payables | 16.07M | (2.99M) | (25.01M) | (13.34M) | 13.8M |
| Other Working Capital | (9.8M) | (27.21M) | 31.47M | 22.39M | 138.35M |
| Other Non-Cash Items | (232K) | (6.5M) | (18.77M) | 17.63M | 163.09M |
| Operating Cash Flow | (42.21M) | (73.93M) | (50.71M) | (14.37M) | 134.36M |
| Capital Expenditures | (14.93M) | (12.76M) | (42.41M) | (44.3M) | (76.71M) |
| Acquisitions (Net) | (9.62M) | (3.82M) | (7.54M) | (1.07M) | (5.4M) |
| Purchases of Investments | 0 | (280.3M) | (189.14M) | (140.24M) | (428.01M) |
| Sales of Investments | 0 | 55.17M | 206.9M | 61.4M | 90.01M |
| Other Investing Activities | (598K) | (557K) | (5.81M) | 182.12M | 27M |
| Investing Cash Flow | (25.15M) | (242.26M) | (33.59M) | 57.91M | (393.12M) |
| Debt Repayment | (66.95M) | 0 | 0 | 0 | 406.27M |
| Common Stock Issued | 0 | 0 | 0 | 5.92M | 35.36M |
| Common Stock Repurchased | (5.6M) | (6.34M) | (8.97M) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 561.73M | 14.2M | 7.37M | (21.46M) | (84.57M) |
| Financing Cash Flow | 489.18M | 7.86M | (1.6M) | (15.54M) | 357.05M |
| Effect of Forex Changes | (1.55M) | (402K) | 17K | (201K) | 7.26M |
| Net Change in Cash | 420.27M | (308.74M) | (85.88M) | 27.8M | 105.56M |
| Free Cash Flow | (57.14M) | (86.69M) | (93.12M) | (58.67M) | 57.65M |
Planet Labs PBC
NYSE:PL
Intrinsic Alpha fair value
Locked
Current Price
$12.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.